Search
for
Sort by
Research 361–390 of 1000+
- Comparison of Current International Guidelines for the Management of Alopecia Areata—Comprehensive Review
- Fractionated CO2 Laser in Combination with Topical Tacrolimus for Chronic Alopecia Areata: A Case Series Study
- Photobiomodulation for Skin Pigmentation Disorders: A Dual-Function Treatment
- Advancements in Bioactive Compounds and Therapeutic Agents for Alopecia: Trends and Future Perspectives
- The Role of Janus Kinase Inhibitors in Dermatology
- Comparative Efficacy and Safety of Janus Kinase Inhibitors Used in Alopecia Areata: A Systematic Review and Meta-analysis
- Medicaid coverage of Janus kinase inhibitors for alopecia areata treatment
- Turning JAK STATic, a peek into the future of dermatology therapeutics
- Janus kinase inhibitors for alopecia areata: a review of clinical data
- Biologic Therapies and Small-Molecule Inhibitors for Dissecting Cellulitis of the Scalp: A Systematic Review
- JAK-centric explainable few-shot gene-expression diagnosis framework for alopecia via MultiPLIER priors and relation-style set-to-set comparison
- Primary cicatricial alopecias are characterized by dysregulation of shared gene expression pathways
- Vitiligo
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- Alopecia areata
- Alopesi Tedavisinde Kullanılan İlaç Tedavileri ve Yeni Yaklaşımlar
- A Bibliometric Analysis of Alopecia Areata Literature over the Past 50 Years.
- JAK Inhibitors for Treatment of Alopecia Areata
- A Concise Review on Novel Drugs Applied in Treatment of Alopecia
- 700 Oncostatin M is upstream of JAK-STAT signaling during the murine hair cycle
- Are Janus kinase (JAK) inhibitors beneficial in the treatment of androgenic alopecia?
- Tofacitinib Citrate for the Treatment of Nail Dystrophy Associated With Alopecia Universalis
- Tofacitinib for the treatment of alopecia areata in preadolescent children
- Irish dermatologists’ experience with JAK inhibitors in alopecia areata
- Efficacy and Tolerability of Brevilin-A, a Natural JAK Inhibitor, in Pediatric Alopecia Areata: A Case Series
- Tangled Causes, Targeted Solutions: A Comprehensive Review of Alopecia.
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- Alopecia Areata: a Comprehensive Review of Pathogenesis and Management
- The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway